Global vaccines market is foreseen to witness a healthy growth outlook between 2020 and 2025, majorly benefiting from a highly regulated industry environment that sets an insurmountable barrier to entry for potential manufacturers. The latest Fairfield Market Research study forecasts over 10% growth for vaccines market during the assessment period, reaching the estimated valuation of more than US$ 54Bn by the end of 2025. With several new vaccines by GSK, Pfizer, and others in their developmental stages, the market is likely to experience the emergence of incremental revenue generation opportunities. Key manufacturers expect improved profit margins with innovative vaccine developments intended to widen the coverage of disease indications. Combination vaccines will serve as a pivotal driver for market growth, especially in the paediatrics segment.
Get a Sample Copy of Vaccines Market:
https://www.fairfieldmarketresearch.com/report/vaccines-market/request-sample
Vaccines Market Experienced a Temporary Revenue Spike amid COVID-19 Outbreak
The report suggests that the COVID-19 pandemic brought a lot of uncertainty to market and will pose a lasting impact on the overall vaccination landscape. The COVID-19 vaccine race offered the biotech companies a major booster during the initial pandemic period. While BioNtech, and Moderna have been among the earliest beneficiaries, some of the top vaccines manufacturing brands like GSK, Merck, Pfizer, and Sanofi preferred to join hands with biotech companies like Curevac, Moderna, BioNTech, and Translate Bio. The Serum Institute of India (SII), and UNICEF signed a long-term supply pact for COVID-19 vaccines that have been developed by Novavax, and AstraZeneca/Oxford. This partnership facilitated the market access of more than a billion vaccine doses for nearly 100 countries under COVAX.
Pneumococcal Conjugate Vaccine Largest Vaccine Category
Pneumococcal diseases remain one of the leading causes of mortality among both adults, and children. Demand for pneumococcal conjugate vaccine (PCV) is expected to climb up in the near future as more than 150 nations have introduced the same under their infant routine immunisation programmes and over 40 are further in the implementation process. Fairfield’s research expects the demand surge to exceed 60 million PCV doses over the next decade as the most populous nations like China, India, and Indonesia come to the fore with this immunisation. The report also expects a sharp demand increase for Human Papilloma Virus (HPV) vaccine, and shingles vaccine.
Exceptional Growth Projected for SEARO, and WPRO
China, India, and other fast-developing nations will continue to be the largest producers and consumers of vaccines, along with the emerging economies that hold greater growth potential. Demand for vaccines in the regions of South and East Asia (SEARO), and Western Pacific (WPRO) is thus forecast to remain on a continuous uptrend. On the other hand, with high-value markets like the US, and Canada, the Americas (AMRO) will remain the largest contributor to global market revenue and will account for nearly 50% of the vaccines market by 2025 end. Compared to the situation in the rest of the world, this region is likely to have a relatively high value for HPV, Influenza (adult), Varicella, and meningococcal vaccines.
Key Players in Global Vaccines Market
Manufacturing of vaccines continues to be concentrated with the global leaders that hold control over 90% of the total market valuation, i.e., GSK, Pfizer, Merck, and Sanofi. In terms of volume, GSK, Sanofi, Serum Institute of India, Bharat Biotech International Limited, and Haffkine collectively account for around 60% of global vaccines production. The report has also covered some other prominent companies in global vaccines market, including CSL Limited (Seqirus), Mitsubishi Tanabe Pharma Corporation, Emergent BioSolutions Inc., Moderna, Sinopharm, and Novavax.
For More Information of Vaccines Market Visit:
https://www.fairfieldmarketresearch.com/report/vaccines-market
About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: [email protected]
Follow Us: LinkedIn
